O. Bülbül Et Al. , "Factors affecting overall survival and progression-free survival in patients with metastatic castration resistant prostate cancer received177Lu PSMA I&T therapy," Hellenic Journal of Nuclear Medicine , vol.23, no.3, pp.229-239, 2020
Bülbül, O. Et Al. 2020. Factors affecting overall survival and progression-free survival in patients with metastatic castration resistant prostate cancer received177Lu PSMA I&T therapy. Hellenic Journal of Nuclear Medicine , vol.23, no.3 , 229-239.
Bülbül, O., ÜNEK, İ. T., KEFİ, A., TUNA, E. B., & BEKİŞ, R., (2020). Factors affecting overall survival and progression-free survival in patients with metastatic castration resistant prostate cancer received177Lu PSMA I&T therapy. Hellenic Journal of Nuclear Medicine , vol.23, no.3, 229-239.
Bülbül, OGÜN Et Al. "Factors affecting overall survival and progression-free survival in patients with metastatic castration resistant prostate cancer received177Lu PSMA I&T therapy," Hellenic Journal of Nuclear Medicine , vol.23, no.3, 229-239, 2020
Bülbül, OGÜN Et Al. "Factors affecting overall survival and progression-free survival in patients with metastatic castration resistant prostate cancer received177Lu PSMA I&T therapy." Hellenic Journal of Nuclear Medicine , vol.23, no.3, pp.229-239, 2020
Bülbül, O. Et Al. (2020) . "Factors affecting overall survival and progression-free survival in patients with metastatic castration resistant prostate cancer received177Lu PSMA I&T therapy." Hellenic Journal of Nuclear Medicine , vol.23, no.3, pp.229-239.
@article{article, author={OGÜN BÜLBÜL Et Al. }, title={Factors affecting overall survival and progression-free survival in patients with metastatic castration resistant prostate cancer received177Lu PSMA I&T therapy}, journal={Hellenic Journal of Nuclear Medicine}, year=2020, pages={229-239} }